During the last session, Aclaris Therapeutics Inc (NASDAQ:ACRS)’s traded shares were 0.75 million, with the beta value of the company hitting 0.43. The 52-week high for the ACRS share is $5.17, that puts it down -254.11 from that peak though still a striking 32.19% gain since the share price plummeted to a 52-week low of $0.99. The company’s market capitalization is $158.09M, and the average trade volume was 915.19K shares over the past three months.
Aclaris Therapeutics Inc (ACRS) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.29. ACRS has a Sell rating from 1 analyst(s) out of 4 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it.
Aclaris Therapeutics Inc (NASDAQ:ACRS) trade information
The stock’s 5-day price performance is 15.87%, and it has moved by 5.80% in 30 days. Based on these gigs, the overall price performance for the year is 39.05%.
The consensus price target of analysts on Wall Street is $7.5, which implies an increase of 80.53% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $3 and $25 respectively. As a result, ACRS is trading at a discount of -1612.33% off the target high and -105.48% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 15.24%. While earnings are projected to return 67.37% in 2025, the next five years will return 25.70% per annum.
ACRS Dividends
Aclaris Therapeutics Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 4.69 million shares, is of VANGUARD GROUP INC’s that is approximately 6.5752% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $5.16 million.
Also, the Mutual Funds coming in first place with the largest holdings of Aclaris Therapeutics Inc (ACRS) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . Data provided on Mar 31, 2025 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 2.12 shares. This amounts to just over 1.95 percent of the company’s overall shares, with a $3.09 million market value. The same data shows that the other fund manager holds slightly less at 1.78, or about 1.64% of the stock, which is worth about $2.59 million.
